Abbott Laboratories reported that earnings rose 18%...

Abbott Laboratories reported that earnings rose 18% in the third quarter to $172.3 million. It attributed the gain to higher productivity, higher volume and a better product mix. The pharmaceutical and medical products company said it also benefited from a weaker U.S. dollar and a lower tax rate.